Structural basis for thrombin activation of a protease-activated receptor: Inhibition of intramolecular liganding

被引:64
作者
Seeley, S
Covic, L
Jacques, SL
Sudmeier, J
Baleja, JD
Kuliopulos, A [1 ]
机构
[1] Tufts Univ, Sch Med, Div Hematol Oncol, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[3] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA
[4] Tufts Univ New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA
来源
CHEMISTRY & BIOLOGY | 2003年 / 10卷 / 11期
关键词
D O I
10.1016/j.chembiol.2003.10.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protease-activated G protein-coupled receptors (PAR1-4) are tethered-ligand receptors that are activated by proteolytic cleavage of the extracellular domain (exodomain) of the receptor. PAR1, the prototypic member of the PAR family, is the high-affinity thrombin receptor of platelets and vascular endothelium and plays a critical role in blood coagulation, thrombosis, and inflammation. Here, we describe the solution structure of the thrombin-cleaved exodomain of PAR1. The side chains of a hydrophobic hirudin-like (Hir) sequence and adjacent anionic motif project into solution. Docking of the exodomain Hir sequence to exosite I of thrombin reveals that the tethered ligand in the cleaved exodomain bends away from thrombin, leaving its active site available to another large macromolecular substrate. The N-terminal ligand is longer than anticipated and forms an intramolecular complex with a region located in the C terminus of the exodomain. Mutational analysis confirmed that this C-terminal region is a ligand binding site for both intra- and intermolecular ligands. A lipidated-ligand binding site peptide was found to be an effective inhibitor of thrombin-induced platelet aggregation.
引用
收藏
页码:1033 / 1041
页数:9
相关论文
共 51 条
[1]   Binding of a thrombin receptor tethered ligand analogue to human platelet thrombin receptor [J].
Ahn, HS ;
Foster, C ;
Boykow, G ;
Arik, L ;
SmithTorhan, A ;
Hesk, D ;
Chatterjee, M .
MOLECULAR PHARMACOLOGY, 1997, 51 (02) :350-356
[2]   Proteinase activated receptor 2: role of extracellular loop 2 for ligand-mediated activation [J].
Al-Ani, B ;
Saifeddine, M ;
Kawabata, A ;
Hollenberg, MD .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (05) :1105-1113
[3]  
Andrade-Gordon P, 2001, J PHARMACOL EXP THER, V298, P34
[4]   Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor [J].
Andrade-Gordon, P ;
Mayanoff, BE ;
Derian, CK ;
Zhang, HC ;
Addo, MF ;
Darrow, AL ;
Eckardt, AJ ;
Hoekstra, WJ ;
McComsey, DF ;
Oksenberg, D ;
Reynolds, EE ;
Santulli, RJ ;
Scarborough, RM ;
Smith, CE ;
White, KB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12257-12262
[5]   Molecular mapping of thrombin-receptor interactions [J].
Ayala, YM ;
Cantwell, AM ;
Rose, T ;
Bush, LA ;
Arosio, D ;
Di Cera, E .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 2001, 45 (02) :107-116
[6]   THE THROMBIN RECEPTOR EXTRACELLULAR DOMAIN CONTAINS SITES CRUCIAL FOR PEPTIDE LIGAND INDUCED ACTIVATION [J].
BAHOU, WF ;
COLLER, BS ;
POTTER, CL ;
NORTON, KJ ;
KUTOK, JL ;
GOLIGORSKY, MS .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1405-1413
[7]   Attacked from within, blood thins [J].
Bahou, WF .
NATURE MEDICINE, 2002, 8 (10) :1082-1083
[8]   IDENTIFICATION OF A NOVEL THROMBIN RECEPTOR SEQUENCE REQUIRED FOR ACTIVATION-DEPENDENT RESPONSES [J].
BAHOU, WF ;
KUTOK, JL ;
WONG, A ;
POTTER, CL ;
COLLER, BS .
BLOOD, 1994, 84 (12) :4195-4202
[9]   Development of potent thrombin receptor antagonist peptides [J].
Bernatowicz, MS ;
Klimas, CE ;
Hartl, KS ;
Peluso, M ;
Allegretto, NJ ;
Seiler, SM .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) :4879-4887
[10]   Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide [J].
Blackhart, BD ;
Ruslim-Litrus, L ;
Lu, CC ;
Alves, VL ;
Teng, W ;
Scarborough, RM ;
Reynolds, EE ;
Oksenberg, D .
MOLECULAR PHARMACOLOGY, 2000, 58 (06) :1178-1187